The difference between primary liver cancer and secondary liver cancer

Written by Sun Wei
Surgical Oncology
Updated on September 09, 2024
00:00
00:00

Primary liver cancer, also commonly referred to as liver cancer, originates in the liver itself and is not transferred from other parts of the body. Secondary liver cancer occurs when the primary tumor originates in another location and then metastasizes to the liver, causing hepatic space-occupying lesions; this is referred to as secondary liver cancer. The main difference between the two types is their origin. Additionally, primary liver cancer is often solitary but may develop intrahepatic or distant metastases as the disease progresses. In cases of secondary liver cancer, multiple intrahepatic metastatic lesions may be discovered at the onset. Moreover, primary liver cancer may often display an elevated alpha-fetoprotein tumor marker, whereas this marker might be normal in secondary liver cancer.

Other Voices

doctor image
home-news-image
Written by Zhang Lu
Obstetrics
1min 1sec home-news-image

Can alpha-fetoprotein diagnose liver cancer?

Alpha-fetoprotein, also known as AFP, reflects the function of the liver and whether there are any diseases present. The accuracy and specificity of alpha-fetoprotein in diagnosing liver cancer are relatively high. In non-pregnant individuals, whether male or female, an elevated alpha-fetoprotein level should raise suspicions of liver disease, and it is advisable to promptly undergo ultrasound or CT scans to determine the presence of liver cancer or other liver diseases. However, during pregnancy, as the fetus grows and develops, a certain amount of alpha-fetoprotein is released. Therefore, when testing the blood of pregnant women, an increase in alpha-fetoprotein is observed. This condition is a physiological change and does not indicate the occurrence of liver diseases such as liver cancer in women. Thus, alpha-fetoprotein can serve as an auxiliary method for diagnosing liver cancer, but only in non-pregnant individuals.

doctor image
home-news-image
Written by Yan Chun
Oncology
1min 8sec home-news-image

Can early-stage liver cancer be cured by resection?

Liver cancer is one of the common malignant tumors of the digestive system. For patients with early-stage liver cancer, clinical cure is possible after curative surgery. This clinical cure refers to instances where liver cancer patients, after undergoing curative surgery, do not show signs of recurrence or metastasis over a period exceeding five years. This means there is no invasion of surrounding tissues and no metastasis to distant organs – effectively, the patients have achieved clinical cure. Patients' survival time exceeds five years, or even longer. Therefore, for patients with early-stage liver cancer, because their lesions are relatively limited, achieving clinical cure is possible following curative surgery. However, as the disease progresses to the mid and late stages, even with aggressive surgery and postoperative adjuvant radiotherapy or chemotherapy, most patients cannot achieve clinical cure.

doctor image
home-news-image
Written by Li Cui
Dentistry
50sec home-news-image

Is bleeding when brushing teeth an early sign of liver cancer?

When a patient has liver cancer, one symptom can be gingival bleeding. Because when a patient has liver cancer, some coagulation factors in the blood are affected, and the patient may frequently experience repeated dental bleeding. Therefore, it is suggested that patients should undergo early diagnostic tests and adopt specific treatment plans. However, repeated gingival bleeding in a patient does not necessarily indicate early-stage liver cancer, as some hematological diseases can also lead to repeated gingival bleeding, such as common thrombocytopenia and some patients with gingivitis. If long-term oral hygiene is neglected, the gingival tissue stays in a state of chronic inflammation, and acute inflammation can lead to bleeding while brushing teeth.

doctor image
home-news-image
Written by Liu Liang
Oncology
42sec home-news-image

How is liver cancer diagnosed?

In clinical practice, if a patient has a history of chronic hepatitis B and imaging tests, such as an enhanced CT or MRI of the liver, suggest a radiological appearance of liver cancer, combined with an AFP level greater than 400 persisting for four weeks, these conditions can support a clinical diagnosis of liver cancer. However, for a confirmed diagnosis, a liver biopsy guided by ultrasound or CT must be performed. The definitive diagnosis of liver cancer relies on identifying cancer cells through pathological examination.

doctor image
home-news-image
Written by Ye Xi Yong
Infectious Diseases
28sec home-news-image

Will "small three yang" lead to liver cancer?

Hepatitis B "minor three positives" refers to positivity in the first, fourth, and fifth items of the complete hepatitis B panel. It is common among patients with acute and chronic hepatitis B. There is no necessary correlation between "minor three positives" and cancer. While some patients with "minor three positives" may develop liver cancer, not all liver cancer patients necessarily progress from this condition, indicating no inevitable link between the two.